|

Trastuzumab-rezetecan Treatment Group Clinical Trials

1 actively recruiting trial

Top Sponsors

  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1

Indications

  • Trastuzumab-rezetecan1
  • HER2-low Breast Cancer1
  • HER2-positive Breast Cancer1
  • Breast Cancer1
  • Cancer1

Other1 trial

Efficacy and Safety of Trastuzumab-rezetecan in HER2-Expressing Breast Cancer

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.